Wall Street Analysts Think West Pharmaceutical (WST) Could Surge 32.33%: Read This Before Placing a Bet

The mean of analysts' price targets for West Pharmaceutical (WST) points to a 32.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Feb 23, 2026

West Announces Quarterly Dividend and Share Repurchase Program

EXTON, Pa., Feb. 17, 2026 /PRNewswire/ -- On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on May 6, 2026 to shareholders of record on April 29, 2026.

PRNewsWire • Feb 17, 2026

Why West Pharmaceutical Services (WST) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Feb 17, 2026

West Pharmaceutical's Under-the-Radar Dividend Worth Watching

West Pharmaceutical Services just sent investors $0.22 per share on February 4, 2026, marking the company's latest quarterly dividend payment.

24/7 Wall Street • Feb 15, 2026

COO vs. WST: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either The Cooper Companies (COO) or West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Feb 13, 2026

West Pharma forecasts 2026 profit above estimates on strong demand for drug components

West Pharmaceutical forecast annual profit above Wall Street estimates on Thursday, after beating fourth-quarter expectations on strong demand for its proprietary products, which include syringes and cartridges for injectable drugs.

Reuters • Feb 12, 2026

West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript

West Pharmaceutical Services, Inc. (WST) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 12, 2026

West Reports Fourth-Quarter and Full-Year 2025 Results

– Strong 4Q results, driven by double-digit organic revenue growth in HVP Components – – Introduces Fiscal 2026 Financial Guidance – EXTON, Pa., Feb. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today reported its financial results for the fourth quarter and full year 2025.

PRNewsWire • Feb 12, 2026

West Pharmaceutical Services (WST) Tops Q4 Earnings and Revenue Estimates

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.04 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $1.82 per share a year ago.

Zacks Investment Research • Feb 12, 2026

West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks Investment Research • Feb 12, 2026